Company intelligence / Profile preview

Veris Health

New York, New York, United Statesverishealth.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Veris Health is advancing an integrated digital cancer care platform that combines remote physiologic data monitoring, patient-reported outcomes, and telehealth to enhance personalized cancer care; the company is preparing to launch its implantable physiological monitor pending FDA clearance expected in 2026. Pilot deployments have demonstrated positive clinical utility at large cancer centers, and a commercial transition is under way with academic partners.

Therapeutic areas: Oncology
Industry: Implantable Medical Devices

Partnerships

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)

Beyond the preview

Go deeper on Veris Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veris Health.

Explore the full profile